Wall Street Is Trading Chips for Chicken: Staples See Best Run Against Tech Since 2001
Consumer staples fund XLP has beaten tech fund XLK by 39.5% in seven weeks, the widest gap since March 2001.
Follow the latest Colgate-Palmolive Company (CL) news and market headlines alongside the live CL price. Stay informed on what's moving CL.
Consumer staples fund XLP has beaten tech fund XLK by 39.5% in seven weeks, the widest gap since March 2001.
Colgate-Palmolive and Kimberly-Clark are both Dividend Kings with strong track records, but they differ in valuation and growth strategy. Colgate-Palmolive trades at a premium (24.3x forward P/E) with growth driven by its Hill's Pet Nutrition segment, while Kimberly-Clark offers a lower valuation (14.7x forward P/E) but faces integration challenges from its Kenvue acquisition. The choice depends on whether investors believe in Colgate's pet food expansion or Kimberly-Clark's expanded hygiene portfolio.
In a comparison of two Consumer Products - Staples sector stocks, BJ's Wholesale Club emerges as the better value opportunity. BJ holds a Zacks Rank #2 (Buy) with a Value grade of B, featuring a forward P/E of 23.54 and PEG ratio of 3.25. Colgate-Palmolive has a Zacks Rank #3 (Hold) with a Value grade of D, showing a forward P/E of 25.02 and PEG ratio of 4.44. BJ's stronger earnings estimate revisions and more attractive valuation metrics make it the superior choice for value investors.
The Consumer Products-Staples industry is navigating a challenging environment marked by elevated raw material, labor, and transportation costs, alongside heightened consumer price sensitivity and spending volatility. Companies are pursuing cost optimization, digital investments, and portfolio optimization strategies. The industry carries a Zacks Industry Rank #194 (bottom 21%), reflecting negative earnings outliers, though it has outperformed the S&P 500 over the past year with a 10.4% gain.
Five Dividend King stocks—Coca-Cola, Procter & Gamble, Johnson & Johnson, PepsiCo, and Colgate-Palmolive—have each increased dividends for at least 50 consecutive years. These recession-resistant companies from consumer staples and healthcare sectors offer reliable income streams and resilience during market volatility, making them attractive for investors seeking stability.
The article discusses a long-term investment strategy for building a 'forever portfolio' with stocks suitable for buy-and-hold investors. It emphasizes the importance of adopting a different mindset when investing for longer time horizons, though the specific stock recommendations are behind a paywall.
News and data on this page is provided by our partnered third-party news and market data provider, with the original publisher credited on each article. All third-party content reflects the views of the original publisher and does not represent the views of MEXC. Price and market data shown on this page are provided by third-party data providers and may be delayed. MEXC offers trading products related to CL, including RealStocks and Stock Futures.
The content on this page is provided for informational purposes only and does not constitute investment, financial, or trading advice. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of any news or market data shown. Trading U.S. stocks and related products involves significant risk, and prices can move sharply in a short period. Past performance does not guarantee future results. Please conduct your own research and assess your financial situation and risk tolerance before making any investment decisions. MEXC is not liable for any losses arising from the use of this information.